Materials · Chemicals & Allied Products

CC Chemours Co SEC Filings & Insider Trading Activity 2026

company
CIK 1627223101 filings
Russell 2000

CC at a glance

Chemours Co (CC, SEC CIK 1627223) filed its latest 10-K annual report on February 24, 2026, a 10-Q quarterly report on November 5, 2026, an 8-K current report on November 18, 2026 and Form 4 insider filings as recently as October 1, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.

  • For the fiscal year ended December 31, 2025 (FY2025), Chemours Co (CC) reported revenue of $5.8 billion (up 0.4% from FY2024) and a net loss of $386.0 million. Diluted EPS was -$2.57.
  • As of September 30, 2026, 36 institutional investment managers tracked by SignalX reported holding Chemours Co (CC) shares worth $1.1 billion in 13F-HR filings.
  • The most recent insider open-market purchase reported on Form 4 was by Familiar Calderon Gerardo on August 12, 2026 of 1,935 shares at $15.53 per share.

Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).

Revenue · FY2025
$5.8B
+0.4% vs prior year
Insiders · 90 days
0 buys · 0 sells
No open-market trades
13F holders
36 funds
$1.1B · −1 vs prior quarter
Latest 8-K
Nov 18, 2026
Item 5.02

AI 10-K Annual Report Analysis

Latest 10-K, fiscal year ended Dec 31, 2025

Full analysis →

Risk Factors

  • Litigation risk: $270 million settlement charge with State of New Jersey for environmental litigation in 2025
  • Geopolitical risk: Sale of Taiwan Titanium site for $360 million pending local regulatory and environmental approvals, mid-2026
  • Operational risk: Washington Works fluoropolymer plant outage caused $20-$25 million Q1 2026 earnings impact due to utility disruption and winter weather
  • Competitive risk: Titanium Technologies mine idled in Florida, shifting to third-party contractor to reduce costs and improve cash flow
  • Financial risk: $1.05 billion senior secured term loan maturity extended to October 2032 with adjusted SOFR +3.5% margin

Management Discussion & Analysis

  • Revenue $5.758B, down 2% YoY; Thermal & Specialized Solutions up $236M (13%) to $2.1B, Titanium Technologies down $143M (6%) to $2.4B, Advanced Performance Materials down $63M (5%) to $1.3B
  • Profitability: Thermal & Specialized Solutions Adj. EBITDA margin 32% vs 31%, Titanium Technologies margin 6% vs 12%, Advanced Performance Materials margin 9% vs 12%
  • Best segment: Thermal & Specialized Solutions Adj. EBITDA $670M, up 17%; Worst segment: Titanium Technologies Adj. EBITDA $145M, down 52%
  • Cash flow & capital: $670M cash ($447M foreign), Revolving Credit Facility availability $955M, Corporate expenses down $75M to $181M, Supply chain financing accelerated $414M receivables collections with $6M discount
  • Outlook/risks: Tax Act impact under ongoing review, operational disruption risks (rail and shutdowns), Moody's Ba3 rating negative outlook, liquidity expected adequate through Feb 2027

Business Overview

  • Core business: global provider of performance chemicals serving diverse industries via three segments; Thermal & Specialized Solutions, Titanium Technologies, Advanced Performance Materials
  • New strategy "Pathway to Thrive" launched in 2024 focusing on operational excellence, growth in data center cooling, next-gen refrigerants, and semiconductor fabrication
  • Strategic shift toward portfolio management emphasizing higher-margin, higher-growth applications and optimizing asset footprint
  • Approximately 2,400 customers served in ~110 countries via 28 production facilities across 8 countries
  • Titanium Technologies segment advancing "Transformation Plan" to become one of lowest-cost, high-quality TiO2 pigment producers

AI summary of the CC 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K

AI 10-Q Quarterly Report Analysis

Latest 10-Q, quarter ended Sep 30, 2026

Risk Factors

  • New risk trigger: none, with no material changes except environmental and health and safety disclosure
  • Regulatory risk: stricter environmental rules could impose fines, remediation costs, or market-access losses
  • Operational risk: permit restrictions or plant shutdowns could delay production and require redundancy investments
  • Financial risk: environmental liabilities may exceed accruals because remediation costs remain difficult to predict
  • Competitive risk: less stringent enforcement abroad could give competitors cost advantages

Management Discussion & Analysis

  • Revenue $1.54B, up $45M or 3% YoY, driven by 5% pricing and partly offset by 2% lower volume
  • Titanium Technologies strongest: sales $680M, up 11%; Adjusted EBITDA margin 13% vs 4% YoY
  • Thermal & Specialized Solutions weakest: sales $510M, down 9%; Adjusted EBITDA margin 27% vs 35% YoY
  • Operating cash flow $263M for nine months vs $127M YoY; financing used $371M, including $1.03B debt repayments
  • Outlook: liquidity sufficient through November 2027; tariff impacts remain uncertain and PFAS restrictions could begin in 2027

AI summary of the CC 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K

AI 8-K Current Report Analysis

The most recent material events, by 8-K item

Filed Nov 18, 2026Full analysis →

Item 5.02: Departure/Appointment of Directors or Principal Officers

  • General Counsel Kristine Wellman retiring from her position effective January 4, 2027
  • Amy Rocklin appointed successor as Senior Vice President, General Counsel and Corporate Secretary

Item EX-99.1: Item EX-99.1

  • General Counsel Kristine Wellman retiring, transitioning to senior counsel on January 4, 2027
  • Wellman continuing advisory support through May 2027, reducing near-term succession disruption
Filed Nov 2, 2026Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • Third-quarter 2026 financial results announced, making the filing relevant to earnings expectations and valuation
  • Detailed results available in Exhibit 99.1, including the company’s press release

Item EX-99.1: Item EX-99.1

  • Q3 sales $1.54B, up 3%; Adjusted EBITDA $200M, up 6%, showing pricing and mix offsetting volume pressure
  • GAAP net income $196M versus $46M, aided by $150M PFAS insurance proceeds, making adjusted earnings more representative of operations
Filed Sep 10, 2026Full analysis →

Item 1.01: Entry into a Material Definitive Agreement

  • $455M North Carolina PFAS settlement payable over 15 years, resolving facility and unrelated contamination claims
  • Chemours responsible for 50%, implying $227.5M of nominal payments under the agreement

Item 7.01: Regulation FD Disclosure

  • Chemours press release dated September 10, 2026 covers PFAS-related cost-sharing arrangements with Corteva and DuPont
  • Investor focus: potential future PFAS liabilities, remediation costs, litigation exposure, and liquidity impact

Item EX-99.1: Item EX-99.1

  • $455 million settlement over 15 years resolves North Carolina PFAS litigation involving Fayetteville Works and AFFF claims
  • Chemours’ 50% share approximately $180 million on a net present value basis, covered by existing accruals

AI summaries of CC 8-K current reports filed with the SEC. What 8-K item codes mean

SignalX for CC

Don't miss the next CC filing

  • Alerts as it files. A push when CC files an 8-K or an insider trades.
  • Fund moves. Which tracked funds opened, added or cut CC, by share count.
  • Ask anything. An AI agent that reads every CC filing and answers with sources.

CC alerts on your phone. Follow it in the SignalX Android app.

Get it on Google Play

Recent Insider Transactions (Form 4)

Latest reported trades by officers, directors and 10% owners

InsiderTypeDatePrice
MATHER COURTNEYASep 30, 2026$13.57
Familiar Calderon GerardoBuyAug 12, 2026$15.53
Will DavidFAug 12, 2026$15.24
Dignam DeniseBuyAug 11, 2026$14.95
Martinko Joseph T.BuyAug 7, 2026$15.47
CRANSTON MARY BBuyAug 7, 2026$15.82
Foley Michael RobertBuyAug 7, 2026$15.51
Cowan AlisterBuyAug 7, 2026$15.62

Financial Summary
XBRL

Annual financial summary from SEC XBRL data
MetricFY2023FY2024FY2025
Profitability
Revenue-$5.8B$5.8B
Gross Profit$1.3B$1.2B$902.0M
Net Income-$86.0M-$386.0M
Gross Margin-19.9%15.5%
Net Margin-1.5%-6.6%
Balance Sheet
Total Assets$8.3B$7.5B$7.4B
Equity-$604.0M$250.0M
ROE-14.2%-154.4%
Per Share
EPS$-1.60$0.57$-2.57
Cash Flow
Operating CF--$633.0M$264.0M
CapEx$370.0M$360.0M$213.0M

Source: XBRL data in Chemours Co (CC)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →

13F Fund Holdings: Quarterly Trend

Latest: Q3 2026

Aggregate CC share value held by 13F filers tracked by SignalX, by quarter.

Quarterly totals table
CC shares held by 13F filers tracked by SignalX, by quarter
QuarterFundsTotal value
Q3 202636$1.06B
Q2 202637$1.54B
Q1 202636$1.65B
Q4 202534$1.00B
Q3 202533$1.43B
Q2 202532$997.5M
Q1 202531$880.6M
Q4 202427$863.4M
Position changes: Q2 2026 → Q3 2026
Top Buyers
Top Sellers
New Positions
Closed Positions

Source: 13F-HR filings on SEC EDGAR (aggregated from 266 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work

CC filing archive

AI analysis pages for each 10-K, 10-Q and 8-K

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling dateAnalysisSEC
8-KNov 18, 2026Analysis-
10-QNov 5, 2026Analysis
8-KNov 2, 2026Analysis-
4Oct 1, 2026--
8-KSep 10, 2026Analysis-
8-KSep 9, 2026Analysis-
4Aug 13, 2026--
4Aug 13, 2026--
4Aug 13, 2026--
4Aug 11, 2026--
4Aug 11, 2026--
4Aug 11, 2026--
4Aug 11, 2026--
4Aug 10, 2026--
4Aug 10, 2026--
10-QAug 5, 2026Analysis
4Aug 4, 2026--
4Aug 4, 2026--
4Aug 4, 2026--
8-KAug 4, 2026Analysis-
4Aug 4, 2026--
4Jul 1, 2026--
8-KJun 24, 2026Analysis-
4May 8, 2026-
4May 8, 2026-

Related Materials companies

All Materials →

CC SEC filings: frequently asked questions

Which institutions hold CC stock?

As of September 30, 2026, the largest Chemours Co (CC) holders among the 13F filers tracked by SignalX were BlackRock ($305.6 million), Vanguard Portfolio Management LLC ($148.1 million), Vanguard Capital Management LLC ($92.2 million), State Street Corp ($82.5 million), JPMorgan Chase & Co ($80.2 million). 13F-HR reports are filed up to 45 days after each quarter ends.

What was CC's revenue in fiscal year 2025?

For the fiscal year ended December 31, 2025 (FY2025), Chemours Co (CC) reported revenue of $5.8 billion (up 0.4% from FY2024) and a net loss of $386.0 million. Diluted EPS was -$2.57. The figures come from the XBRL data in the 10-K.

What are the main risks in CC's latest 10-K?

In the 10-K filed February 24, 2026, Chemours Co (CC) flagged: Litigation risk: $270 million settlement charge with State of New Jersey for environmental litigation in 2025. Geopolitical risk: Sale of Taiwan Titanium site for $360 million pending local regulatory and environmental approvals, mid-2026. (AI summary of the Risk Factors section.)

What did CC report in its latest 8-K?

Chemours Co (CC) filed an 8-K on November 18, 2026 reporting Item 5.02 (Departure/Appointment of Directors or Principal Officers). General Counsel Kristine Wellman retiring from her position effective January 4, 2027.

What are the latest CC SEC filings?

Chemours Co (CC) filed its latest 10-K annual report on February 24, 2026, a 10-Q quarterly report on November 5, 2026, an 8-K current report on November 18, 2026 and a Form 4 insider filing on October 1, 2026.

What is CC's SEC CIK number?

Chemours Co (CC)'s SEC Central Index Key (CIK) is 1627223. EDGAR lists every CC filing under that number.

Ask anything about CC

The research agent reads CC's filings, financials, insider trades and 13F holders, then answers with sources.